News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
513,170 Results
Type
Article (30251)
Company Profile (369)
Press Release (482542)
Multimedia
Podcasts (135)
Webinars (18)
Section
Business (136210)
Career Advice (439)
Deals (24793)
Drug Delivery (101)
Drug Development (66975)
Employer Resources (67)
FDA (12451)
Job Trends (10023)
News (239328)
Policy (19318)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (2)
2027 Genetown Elite (3)
2027 Genetown Standard (4)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (1863)
Academic (1)
Accelerated approval (44)
ADA (44)
Adcomms (20)
Allergies (167)
Alliances (37137)
ALS (206)
Alzheimer's disease (1655)
Antibody-drug conjugate (ADC) (505)
Approvals (12980)
Artificial intelligence (628)
ASCO (293)
Autoimmune disease (325)
Automation (51)
Bankruptcy (177)
Best Places to Work (8468)
BIOSECURE Act (15)
Biosimilars (207)
Biotechnology (260)
Bladder cancer (181)
Brain cancer (69)
Breast cancer (709)
Cancer (5690)
Cardiovascular disease (483)
Career advice (406)
Career pathing (21)
CAR-T (345)
CDC (14)
Celiac Disease (1)
Cell therapy (932)
Cervical cancer (45)
Clinical research (59460)
Collaboration (2135)
Commercialization (1)
Company closure (3)
Compensation (1102)
Complete response letters (73)
COVID-19 (2129)
CRISPR (113)
C-suite (1118)
Cystic fibrosis (143)
Data (7868)
Decentralized trials (1)
Denatured (48)
Depression (153)
Dermatology (83)
Diabetes (606)
Diagnostics (5380)
Digital health (54)
Diversity (9)
Diversity, equity & inclusion (19)
Drug discovery (335)
Drug pricing (99)
Drug shortages (19)
Duchenne muscular dystrophy (298)
Earnings (55209)
Editorial (44)
Employer branding (12)
Employer resources (61)
Events (89026)
Executive appointments (1032)
FDA (15933)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (20)
Frontotemporal dementia (35)
Funding (1649)
Gene editing (244)
Generative AI (54)
Gene therapy (731)
GLP-1 (953)
Government (2613)
Grass and pollen (8)
Guidances (338)
Healthcare (13074)
Hematology (194)
HIV (77)
Huntington's disease (57)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (114)
Immunology and inflammation (277)
Immuno-oncology (94)
Indications (197)
Infectious disease (2428)
Inflammatory bowel disease (216)
Inflation Reduction Act (11)
Influenza (111)
Intellectual property (281)
Interviews (54)
IPO (12188)
IRA (24)
Job creations (1940)
Job search strategy (350)
JPM (55)
Kidney cancer (19)
Labor market (56)
Layoffs (396)
Leadership (22)
Legal (3258)
Liver cancer (88)
Longevity (30)
Lung cancer (751)
Lymphoma (442)
Machine learning (57)
Management (17)
Manufacturing (950)
Marketing (1)
MASH (202)
Medical affairs (1)
Medical device (9414)
Medtech (9508)
Mergers & acquisitions (13758)
Metabolic disorders (1463)
mRNA (211)
Multiple sclerosis (179)
NASH (18)
Neurodegenerative disease (423)
Neuropsychiatric disorders (97)
Neuroscience (3127)
Neurotech (1)
NextGen: Class of 2026 (3699)
Non-profit (2716)
Now hiring (55)
Obesity (645)
Opinion (208)
Ovarian cancer (218)
Pain (205)
Pancreatic cancer (313)
Parkinson's disease (366)
Partnered (29)
Patents (538)
Patient recruitment (675)
Peanut (61)
People (44704)
Pharmaceutical (66)
Pharmacy benefit managers (10)
Phase 1 (18971)
Phase 2 (26178)
Phase 3 (19673)
Pipeline (8745)
Policy (179)
Postmarket research (1833)
Preclinical (7888)
Press Release (60)
Prostate cancer (309)
Psychedelics (63)
Radiopharmaceuticals (331)
Rare diseases (1096)
Real estate (3724)
Recruiting (28)
Regulatory (18292)
Reports (30)
Research institute (1926)
Resumes & cover letters (49)
Rett syndrome (41)
RNA editing (30)
RSV (62)
Schizophrenia (173)
Series A (293)
Series B (204)
Service/supplier (5)
Sickle cell disease (122)
Special edition (23)
Spinal muscular atrophy (155)
Sponsored (43)
Startups (2741)
State (1)
Stomach cancer (12)
Supply chain (109)
Tariffs (39)
The Weekly (85)
Vaccines (880)
Venture capital (106)
Weight loss (398)
Women's health (109)
Worklife (5)
Date
Today (95)
Last 7 days (407)
Last 30 days (2429)
Last 365 days (26664)
2026 (13423)
2025 (26540)
2024 (30140)
2023 (33604)
2022 (43709)
2021 (46636)
2020 (42590)
2019 (32183)
2018 (24091)
2017 (24505)
2016 (22907)
2015 (26832)
2014 (20021)
2013 (15812)
2012 (16606)
2011 (16263)
2010 (14959)
Location
Africa (461)
Alabama (80)
Alaska (4)
Arizona (189)
Arkansas (13)
Asia (32885)
Australia (5693)
California (11851)
Canada (3230)
China (1482)
Colorado (486)
Connecticut (483)
Delaware (404)
Europe (74461)
Florida (1644)
Georgia (397)
Hawaii (4)
Idaho (37)
Illinois (885)
India (95)
Indiana (552)
Iowa (17)
Japan (577)
Kansas (114)
Kentucky (27)
Louisiana (40)
Maine (42)
Maryland (1352)
Massachusetts (9130)
Michigan (342)
Minnesota (548)
Mississippi (4)
Missouri (120)
Montana (32)
Nebraska (16)
Nevada (113)
New Hampshire (67)
New Jersey (3266)
New Mexico (28)
New York (3105)
North Carolina (1490)
North Dakota (10)
Northern California (5997)
Ohio (335)
Oklahoma (21)
Oregon (32)
Pennsylvania (2371)
Puerto Rico (29)
Rhode Island (38)
South America (650)
South Carolina (31)
Southern California (4682)
Tennessee (153)
Texas (1720)
United States (41690)
Utah (249)
Virginia (277)
Washington D.C. (65)
Washington State (983)
West Virginia (2)
Wisconsin (118)
Wyoming (2)
513,170 Results for "global blood therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Approvals
AbbVie snags FDA’s first ADC approval for ultra-rare blood cancer
Decnupaz is the first antibody-drug conjugate for blastic plasmacytoid dendritic cell neoplasm, an ultra-rare and aggressive blood cancer.
May 28, 2026
·
1 min read
·
Tristan Manalac
Approvals
AstraZeneca wins nod for blood pressure pill, opening new class of hypertension drugs
Baxfendy, the first aldosterone synthase inhibitor to be approved by the FDA for high blood pressure, is among the products AstraZeneca is relying on to hit its 2030 goal of $80 billion in revenue.
May 18, 2026
·
1 min read
·
Tristan Manalac
Cancer
Lilly sees quick return on $2.3B Ajax buy as blood cancer drug shows early efficacy
Eli Lilly’s new JAK2 inhibitor—which it obtained from the recent acquisition of Ajax Therapeutics—reduced spleen volume by more than a third in 70% of patients with myelofibrosis.
June 15, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Hemab Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
May 27, 2026
·
1 min read
Press Releases
Roche launches the cobas MPX-E assay, a new 4-in-1 donor screening test to further safeguard the global blood supply
March 30, 2026
·
4 min read
Press Releases
Keros Therapeutics Announces Participation at Goldman Sachs 47th Annual Global Healthcare Conference
June 2, 2026
·
1 min read
Press Releases
Aldeyra Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
June 2, 2026
·
1 min read
Press Releases
AN2 Therapeutics to Present at 2026 Jefferies Global Healthcare Conference
May 21, 2026
·
1 min read
Press Releases
Whitehawk Therapeutics to Present at the Jefferies 2026 Global Healthcare Conference
May 29, 2026
·
1 min read
Press Releases
Pelthos Therapeutics to Participate in 2026 Jefferies Global Healthcare Conference
May 29, 2026
·
1 min read
1 of 51,317
Next
